Home » Topics » BioWorld Science

BioWorld Science
RSS

SARS-CoV-2 neutralizing antibody JS-016 begins phase I study in China

June 8, 2020

New arginase inhibitors presented by Arcus Biosciences

June 8, 2020

Sleep deprivation kills through punch to the gut

June 8, 2020

Inception IBD discloses new VNN1 inhibitors

June 8, 2020

Qilu Regor Therapeutics identifies GLP-1 receptor agonists

June 8, 2020

TES Pharma describes ACMSD inhibitors

June 8, 2020

BeiGene patents new MAP4K1 inhibitors

June 8, 2020

Survival improved with apatinib in Chinese patients with pretreated hepatocellular carcinoma

June 8, 2020

Phase I data presented for anti-EGFR ADC MRG-003 in relapsed/refractory solid tumors

June 8, 2020

Series B financing extension to support Artax's development of AX-158 for autoimmune diseases

June 8, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...